Siglec-5 is a novel marker of critical limb ischemia in patients with diabetes.

about

MiR-323b-5p acts as a novel diagnostic biomarker for critical limb ischemia in type 2 diabetic patients

P2860

Q57286519-2D76E6C2-2D2D-4114-AA3C-AE7C7D7171FC

P2860

Siglec-5 is a novel marker of critical limb ischemia in patients with diabetes.

Item

http://www.wikidata.org/entity/Q41200652

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Siglec-5 is a novel marker of critical limb ischemia in patients with diabetes.

@en

type

Item

label

Siglec-5 is a novel marker of critical limb ischemia in patients with diabetes.

@en

prefLabel

Siglec-5 is a novel marker of critical limb ischemia in patients with diabetes.

@en

P1476

Siglec-5 is a novel marker of critical limb ischemia in patients with diabetes.

@en

P2093

Ai-Ping Deng

http://www.w3.org/2001/XMLSchema#string

Bing-Hui Li

http://www.w3.org/2001/XMLSchema#string

Ju-Yi Li

http://www.w3.org/2001/XMLSchema#string

Lin Zhu

http://www.w3.org/2001/XMLSchema#string

Ling Wang

http://www.w3.org/2001/XMLSchema#string

Si Jin

http://www.w3.org/2001/XMLSchema#string

Xiang-Li Bai

http://www.w3.org/2001/XMLSchema#string

Xiao-Yan Yang

http://www.w3.org/2001/XMLSchema#string

Xiong Jia

http://www.w3.org/2001/XMLSchema#string

Xiu-Fang Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Immunoproteomic Profiling of Antiviral Antibodies in New-Onset Type 1 Diabetes Using Protein Arrays

Characterization of human sialoadhesin, a sialic acid binding receptor expressed by resident and inflammatory macrophage populations

Structural implications of Siglec-5-mediated sialoglycan recognition

Tumor self-seeding by circulating cancer cells

Medical treatment of peripheral arterial disease

Siglecs and their roles in the immune system

Cystatin C: a strong marker for lower limb ischemia in Chinese type 2 diabetic patients?

The pathobiology of diabetic complications: a unifying mechanism

Soluble Siglec-5 associates to PSGL-1 and displays anti-inflammatory activity.

A comparative study of the asparagine-linked oligosaccharides on siglec-5, siglec-7 and siglec-8, expressed in a CHO cell line, and their contribution to ligand recognition.

P2888

s41598-017-11820-x

P304

11272

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-11820-X

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1091558500

http://www.w3.org/2001/XMLSchema#string

P698

28900239

http://www.w3.org/2001/XMLSchema#string

P932

5595823

http://www.w3.org/2001/XMLSchema#string

Siglec-5 is a novel marker of critical limb ischemia in patients with diabetes.

about

P2860

P2860

Siglec-5 is a novel marker of critical limb ischemia in patients with diabetes.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P407

P433

P478

P577

P6179

P698

P932